Norway - Vaccines
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 31 May 2019
- Opportunity publication date
- 19 April 2019
- Category
- 33651600
- Value of contract
- £5m-50m
- Your guide to exporting
Description
The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender competition.The procurement shall be implemented as an open tender contest in accordance with the Public Procurement Regulations' Parts 1 and 3. The procurement shall be implemented electronically via the CTM-KGV portal (Eu-Supply) and the tender notice is published in Doffin and TED.
- Opportunity closing date
- 31 May 2019
- Value of contract
- £5m-50m
About the buyer
- Address
- Folkehelseinstituttet Lovisenberggata 8 Oslo 0456 Norway
- Contact
- ole.andreas.fuglesang@fhi.no
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.